History
Cantab Biopharmaceuticals Ltd has its roots within two of the UK’s oldest biotechnology companies; Cantab Pharmaceuticals and Xenova. The time line below shows significant events in the company’s evolution.
- 1989
Immunology Ltd spun out of the University of Cambridge - 1991
Immunology Ltd changed its name to Cantab Pharmaceuticals - 1991
IPO NASDAQ - 1993
IPO LSE - 1999
First 3rd party process development and GMP manufacturing contract signed with Pharmexa - 2001
Merger between Cantab and Xenova; corporate entity becomes Xenova Group - 2003
Merger between Xenova Group and KS Biomedix - 2005
Xenova Group acquired by Celtic Pharmaceutical Holdings LP (CP1) and de-listed from public markets - 2007
Cambridge site spun out of Xenova as Cambridge Biomanufacturing Ltd (trading as Xenova Biomanufacturing) to focus on contract process development and GMP manufacturing services - 2009
Cambridge Biomanufacturing Ltd acquired by Celtic Pharma Holdings LLP (CP2) and re-named Cantab Biopharmaceuticals Ltd